Ada Popolo

Dr. Ada Popolo

Department of Pharmacy, “University of Salerno”, Fisciano, Salerno, Italy
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2013 in Free Radical Research
Verified
Journal Article
Closed access
APAda Popolo
Ada Popolo
GAG. Autore
G. Autore
APA. Pinto
A. Pinto
STEFANIA MARZOCCOSTEFANIA MARZOCCO
STEFANIA MARZOCCO
Oxidative response regulates many physiological response in human health, but if not properly regulated it could also lead to a number of deleterious effects. The importance of oxidative stress injury depends on the molecular target, the severity of the stress, and the mechanism by which the oxidative stress is imposed: it has been implicated in several diseases including cancer, neurodegenerative diseases, malaria, rheumatoid arthritis and cardiovascular and kidney disease. Most of the common diseases, such as hypertension, atherosclerosis, heart failure, and renal dysfunction, are associated with vascular functional and structural alterations including endothelial dysfunction, altered contractility, and vascular remodeling. Common to these processes is increased bioavailability of reactive oxygen species (ROS), decreased nitric oxide (NO) levels, and reduced antioxidant capacity. Oxidative processes are up-regulated also in patients with chronic renal failure (CRF) and seem to be a cause of elevated risk of morbidity and mortality in these patients. In this review, we highlight the role of oxidative stress in cardiovascular and renal disease.

1 December 2015 in European Journal of Pharmacology
Verified
Journal Article
Closed access
PMPecoraro Michela
Pecoraro Michela
VVVerrilli Velia
Verrilli Velia
PAPinto Aldo
Pinto Aldo
APAda Popolo
Ada Popolo

1 January 2006 in Life Sciences
Verified
Journal Article
Closed access
APAlessandra Tiziana Peana
Alessandra Tiziana Peana
SMStefania Marzocco
Stefania Marzocco
APAda Popolo
Ada Popolo
APAldo Pinto
Aldo Pinto

30 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SASimona Adesso
Simona Adesso
APAda Popolo
Ada Popolo
GBGiuseppe Bianco
Giuseppe Bianco
RAFFAELLA SORRENTINORAFFAELLA SORRENTINO
RAFFAELLA SORRENTINO
APAldo Pinto
Aldo Pinto
STEFANIA MARZOCCOSTEFANIA MARZOCCO
STEFANIA MARZOCCO
Indoxyl sulphate (IS) is a protein-bound uremic toxin that results from the metabolism of dietary tryptophan normally excreted by kidney through the proximal tubules. Thus the toxin accumulates in the blood of patients with impaired renal function such as in chronic kidney disease (CKD). High IS serum levels in patients with CKD suggest its involvement in CKD progression and in the onset of complications. Its presence in plasma is also a powerful predictor of overall and cardiovascular morbidity/mortality. IS is a well known nephrovascular toxin but very little is known regarding its effects on the immune system and in particular during inflammation. In this study we examined the effect of IS on macrophage activation in response to lipopolysaccharide from E. coli (LPS), a gram negative bacterial endotoxin associated with inflammation and septic shock. To simulate the uremic condition, J774A.1 macrophages were incubated with IS at concentrations observed in uremic patients (1000–62.5 µM) both alone and during LPS challenge. IS alone induced release of reactive oxygen species (ROS), through a mechanism involving pro- and anti-oxidant systems, and alteration in intracellular calcium homeostasis. When added to J774A.1 macrophages in presence of LPS, IS significantly increased the nitric oxide (NO) release, inducible nitric oxide synthase (iNOS) and cycloxygenase-2 (COX-2) expression. IS pre-treatment was also associated with an increase in tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) production by macrophages stimulated with LPS. Mechanistic studies revealed that IS increased LPS-induced NF-kB nuclear translocation, ROS release and altered calcium concentrations, mainly because of mitochondrial calcium overloading. Moreover also in primary mouse peritoneal macrophages IS enhances the inflammatory response to LPS increasing ROS, NO, iNOS, COX-2, TNF-α, IL-6 and NF-kB levels. This study provides evidences that IS stimulates macrophage function and enhances inflammatory reasponse associated with LPS, thus contributing to altered immune response dysfunctions observed in CKD.

27 August 2014 in Amino Acids
Verified
Journal Article
Closed access
PDF file
APAda Popolo
Ada Popolo
SASimona Adesso
Simona Adesso
APAldo Pinto
Aldo Pinto
GAGiuseppina Autore
Giuseppina Autore
STEFANIA MARZOCCOSTEFANIA MARZOCCO
STEFANIA MARZOCCO

Verified
Journal Article
Open access
PDF file
RVRoberta Vitale
Roberta Vitale
STEFANIA MARZOCCOSTEFANIA MARZOCCO
STEFANIA MARZOCCO
APAda Popolo
Ada Popolo
Cardiotoxicity is the main side effect of several chemotherapeutic drugs. Doxorubicin (Doxo) is one of the most used anthracyclines in the treatment of many tumors, but the development of acute and chronic cardiotoxicity limits its clinical usefulness. Different studies focused only on the effects of long-term Doxo administration, but recent data show that cardiomyocyte damage is an early event induced by Doxo after a single administration that can be followed by progressive functional decline, leading to overt heart failure. The knowledge of molecular mechanisms involved in the early stage of Doxo-induced cardiotoxicity is of paramount importance to treating and/or preventing it. This review aims to illustrate several mechanisms thought to underlie Doxo-induced cardiotoxicity, such as oxidative and nitrosative stress, inflammation, and mitochondrial dysfunction. Moreover, here we report data from both in vitro and in vivo studies indicating new therapeutic strategies to prevent Doxo-induced cardiotoxicity.